SUMMARY The presence of paraproteins in the sera of 10 patients with chronic lymphocytic leukaemia (CLL) was investigated using immunoisoelectric focusing. Monoclonal immunoglobulins were found in nine of these 10 sera. Five sera contained a single monoclonal IgM paraprotein, one serum contained a single monoclonal IgG paraprotein, while three sera contained more than one monoclonal paraprotein-namely, IgM + IgD, IgM + IgG, and IgM + IgD + IgG. The results indicate that the malignant B cells of CLL may be at a later stage of differentiation than previously assumed and serum monoclonal immunoglobulin could be of value as a tumour marker.
Chronic lymphocytic leukaemia (CLL) is a disease involving malignant proliferation of a clone of B lvmphocytes, but the stage of differentiation of CLL cells along the continuum from B lymphocyte precursor to mature plasma cell is still a matter of some controversy. Previous work has shown serum paraprotein in fewer than 10% of cases of CLL;' 2 this has led to the assumption that the proliferating clone in CLL is derived from a lymphocyte as yet too immature to secrete immunoglobulin and that further maturation to immunoglobulin production does not normally occur.34
In this paper we present data on 10 patients with CLL whose sera were investigated by immunoisoelectric focusing, a technique which is highly sensitive in the detection of monoclonal immunoglobulins. 2, 6, 7, 8 , and 10 had received no treatment; the remainder had been treated intermittently with a combination of chlorambucil and prednisolone.
Antisera were obtained from the following sources: anti-IgG and anti-IgD from the Scottish Antibody Production Unit (Law Hospital, Carluke, Lanarkshire, UK); anti-IgM from BoehringerMannhiem; and anti-K and anti-X light chains from Dakopatts. The specificity of antisera was tested against monoclonal immunoglobulin of known isotype.
Immunoisoelectric focusing was performed as described in detail elsewhere.5 Briefly, sera were focused on agarose isoelectric focusing gels containing ampholytes which produce a pH gradient of 3-10 (Pharmacia Fine Chemicals, LKB). After focusing, one track was cut from the gel-for example, track 4 ( Fig. 1 )-and placed in 10% trichloroacetic acid to fix the proteins in the gel. The remaining tracks were overlaid with strips of cellulose acetate membrane soaked in specific antisera and incubated for 2-3 h at 37°C. After fixation or incubation, the tracks were washed, dried, and stained.
Immunoelectrophoresis was performed as described previously5 using Corning Universal electrophoresis plates. Serum immunoglobulin concentrations were measured by radial immunodiffusion on plates supplied by Boehringer-Mannheim.
Results
The With serum from patient 4 ( Fig. 2) there was no detectable abnormality with immunoelectrophoresis, whereas immunoisoelectric focusing showed two monoclonal immunoglobulins, which were identified as IgM (K) and IgG (X) (tracks 2 and 3 and tracks 1 and 4 respectively).
Total serum immunoglobulin concentrations in the 10 patients with CLL were measured by radial immunodiffusion. In only two cases were values above the normal range (see Table) : patient 4 had an IgM concentration of 1X95 mg/ml and patient 8 had an IgG concentration of 16-2 mg/ml.
Immunoelectrophoresis showed no monoclonal immunoglobulin in all 10 cases studied. Patients with CLL and detectable serum paraproteinaemia are well documented' but have been assumed to represent a small minority of cases, estimates ranging from 3% to 6%.' 2 The results reported here cast considerable doubt on this conclusion as nine of 10 patients with CLL had measurable concentrations of monoclonal immunoglobulin when sufficiently sensitive techniques were used. We have shown previously that immunoisoelectric focusing is a more sensitive method for detecting serum paraproteinaemia than techniques currently in use5 and our present results indicate that the absence of monoclonal serum immunoglobulin reported in other studies of CLL is due to Serum paraproteins in chronic lymphocytic leukaemia insufficient sensitivity of the techniques used rather than failure of secretion by the malignant B cell clone.
Discussion
In an earlier report of two patients with CLL and serum paraproteinaemia, Fu et a!7 showed that the serum paraprotein, the surface IgM of the leukaemic lymphocytes, and the intracellular IgM were idiotypically ioentical and concluded that the serum paraprotein was the product of the malignant B cell clone. We are currently investigating the idiotypic nature and source of the monoclonal immunoglobulin in our patients' sera in order to confirm this possibility. In conclusion, this is the first study to report such a high incidence of easily detectable monoclonal immunoglobulins in the sera of patients with CLL. The high proportion of patients with circulating paraproteins indicates that monoclonal immunoglobulin could be useful as a tumour marker for CLL and other B cell neoplasia and our results may contribute to the understanding of the natural history and malignant processes concerned in these diseases.
